The software AI darling Palantir (PLTR) has seen its stock price rise by around 360% over the last twelve months, making it one of the most hyped stocks of the moment. Despite this dramatic ...

Donald Trump is courting a cadre of Silicon Valley insiders to join his second administration.

Tampa General Hospital (TGH) announced today it has appointed Melissa Golombek as executive vice president and chief ...

Renovaro Biosciences ( (RENB) ) just unveiled an update.

Palantir stock climbed an incredible 340% in 2024. The company is accelerating its revenue growth in the United States. Shares look overvalued at current prices, even for investors focused on the ...

Palantir was able to accelerate its overall revenue growth despite challenges in Europe and the Middle East, and if this top-line trend holds in 2025, the stock is likely to keep rising.

Palantir's valuation is unsustainable, trading at extreme multiples, with a P/S ratio of 64.7x and forward P/E of 203x, far exceeding sector medians. Heavy reliance on government contracts ...

Palantir's stock surged nearly 4x in 2024 due to strong fundamentals and AI-driven bullish sentiment. Financial performance remains strong, including Q3 revenue growth of 30% yoy and a 38% ...

Palantir's top line in the first quarter of 2024 was up 21% year over year, followed by a 27% increase in Q2. The company reported a 30% year-over-year jump in revenue in the third quarter of 2024 ...

Palantir Technologies (NASDAQ: PLTR) stock simply took off in 2024, registering eye-popping gains of 340% as of this writing and handsomely crushing the 23% gains registered by the Nasdaq ...

The Nasdaq 100 index recently completed its latest rebalancing. Two popular stocks, Palantir Technologies and MicroStrategy, were the big notable additions. They have been among the hottest buys ...

Palantir (NASDAQ: PLTR) was one of the best-performing stocks of 2024. The analytics and software management platform for government agencies, the military, and big business soared 340% for the ...